Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide.↗
PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1
Complete submitted registry timeline
ClinicalTrials.gov lists these public versions with submitted dates from September 8, 2011 through April 24, 2017. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.
Source-declared changed modules: None listed for this version
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Eligibility, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Outcome Measures, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Study Design, Study Status
Source-declared changed modules: Adverse Events, Arms and Interventions, Baseline Characteristics, Conditions, Contacts/Locations, Eligibility, IPDSharing, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Description, Study Status
ClinicalTrials.gov · Official source · Source checked August 13, 2026